Literature DB >> 30323866

Role of double knockdown of tPA and MMP-9 on regulating the left ventricular function and remodeling followed by transverse aortic constriction-induced hypertrophic cardiomyopathy in mice.

Pei-Hsun Sung1,2, Sarah Chua1, Kuan-Hung Chen3, Cheuk-Kwan Sun4, Yi-Chen Li1, Chi-Ruei Huang1, Chi-Wen Luo1, Han-Tan Chai1, Hung-I Lu5, Hon-Kan Yip1,6,2,7,8.   

Abstract

This study tested the hypothesis that extracellular matrix accumulation in tPA-/-/MMP-9-/- [double-knockout (DKO)] may be protective against left ventricular (LV) remodeling and dysfunction following transverse aortic constriction (TAC)-induced hypertrophic cardiomyopathy in mice. Wild-type C57BL/6 mice (n = 20) were equally categorized into sham-control (SC1) and TAC1. Similarly, DKO mice (n = 20) were equally divided into two groups (i.e., SC2 and ATC2). By days 28/60 after TAC, LV ejection fraction (LVEF) was significantly higher in TAC2 than TAC1, whereas LV end-systolic/diastolic dimensions displayed an opposite pattern to LVEF between the two groups (all P < 0.05). By day 90, LVEF was significantly higher in SC groups than that in TAC1 and TAC2 without notable difference between the latter two groups, whereas LV end-systolic/diastolic dimensions, cardiomyocyte size and right-ventricular systolic pressure showed an opposite pattern compared with LVEF in all groups (all P < 0.01). Total heart weight was highest in TAC1 and significantly higher in TAC2 than those in the SC groups (P < 0.01). LV myocardial protein expressions of inflammation (TNF-α/NF-κβ), apoptosis (mitochondrial-Bax/cleaved caspase-3/PARP), oxidative stress (NOX-1/NOX-2/oxidized protein), fibrosis (Smad3/TGF-β), DNA/mitochondrial damage (γ-H2AX/cytosolic-cytochrome-C) and LV hypertrophy/pressure-overload (β-MHC/BNP) biomarkers were significantly increased in TAC2 compared to TAC1 and SC groups, and significantly increased in TAC1 compared to SC groups (all P < 0.001). Histopathology demonstrated that the fibrotic/collagen-deposition areas and sarcomere length exhibited an identical pattern to inflammation among the four groups (all P < 0.0001). In conclusion, although tPA-/-/MMP-9-/- seemed to preserve cardiac function in an experimental setting of hypertrophic cardiomyopathy at an early stage, it failed to exert long-term protective effect.

Entities:  

Keywords:  Double knockout mice; heart function; hypertrophic cardiomyopathy; transverse aortic constriction

Year:  2018        PMID: 30323866      PMCID: PMC6176237     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  27 in total

1.  Impact of metalloproteinases on left ventricular remodeling and heart failure events in patients with hypertrophic cardiomyopathy.

Authors:  Hiroaki Kitaoka; Toru Kubo; Makoto Okawa; Kayo Hayato; Naohito Yamasaki; Yoshihisa Matsumura; Yoshinori L Doi
Journal:  Circ J       Date:  2010-04-20       Impact factor: 2.993

2.  Early Administration of Carvedilol Protected against Doxorubicin-Induced Cardiomyopathy.

Authors:  Yung-Lung Chen; Sheng-Ying Chung; Han-Tan Chai; Chih-Hung Chen; Chu-Feng Liu; Yi-Ling Chen; Tien-Hung Huang; Yen-Yi Zhen; Pei-Hsun Sung; Cheuk-Kwan Sun; Sarah Chua; Hung-I Lu; Fan-Yen Lee; Jiunn-Jye Sheu; Hon-Kan Yip
Journal:  J Pharmacol Exp Ther       Date:  2015-10-28       Impact factor: 4.030

3.  Cardiomyocyte-specific Bmal1 deletion in mice triggers diastolic dysfunction, extracellular matrix response, and impaired resolution of inflammation.

Authors:  Kevin A Ingle; Vasundhara Kain; Mehak Goel; Sumanth D Prabhu; Martin E Young; Ganesh V Halade
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-10-02       Impact factor: 4.733

4.  Acute left ventricular remodeling following myocardial infarction: coupling of regional healing with remote extracellular matrix expansion.

Authors:  William Chan; Stephen J Duffy; David A White; Xiao-Ming Gao; Xiao-Jun Du; Andris H Ellims; Anthony M Dart; Andrew J Taylor
Journal:  JACC Cardiovasc Imaging       Date:  2012-09

5.  Tissue plasminogen activator enhances mobilization of endothelial progenitor cells and angiogenesis in murine limb ischemia.

Authors:  Hon-Kan Yip; Cheuk-Kwan Sun; Tzu-Hsien Tsai; Jiunn-Jye Sheu; Ying-Hsien Kao; Yu-Chun Lin; Yow-Ling Shiue; Yung-Lung Chen; Han-Tan Chai; Sarah Chua; Sheung-Fat Ko; Steve Leu
Journal:  Int J Cardiol       Date:  2012-10-09       Impact factor: 4.164

6.  The cardioprotective effect of melatonin and exendin-4 treatment in a rat model of cardiorenal syndrome.

Authors:  Sarah Chua; Fan-Yen Lee; Hsin-Ju Chiang; Kuan-Hung Chen; Hung-I Lu; Yen-Ta Chen; Chih-Chao Yang; Kun-Chen Lin; Yi-Ling Chen; Gour-Shenq Kao; Chih-Hung Chen; Hsueh-Wen Chang; Hon-Kan Yip
Journal:  J Pineal Res       Date:  2016-09-26       Impact factor: 13.007

Review 7.  Independent relationship of left atrial size and mortality in patients with heart failure: an individual patient meta-analysis of longitudinal data (MeRGE Heart Failure).

Authors:  Andrea Rossi; Pier Luigi Temporelli; Miguel Quintana; Frank L Dini; Stefano Ghio; Graham S Hillis; Allan L Klein; Nina Ajmone Marsan; David L Prior; Cheuk Man Yu; Katrina K Poppe; Robert N Doughty; Gillian A Whalley
Journal:  Eur J Heart Fail       Date:  2009-10       Impact factor: 15.534

Review 8.  Pathological ventricular remodeling: mechanisms: part 1 of 2.

Authors:  Jana S Burchfield; Min Xie; Joseph A Hill
Journal:  Circulation       Date:  2013-07-23       Impact factor: 29.690

9.  CCN2 plays a key role in extracellular matrix gene expression in severe hypertrophic cardiomyopathy and heart failure.

Authors:  Tatiana Tsoutsman; Xiaoyu Wang; Kendra Garchow; Bruce Riser; Stephen Twigg; Christopher Semsarian
Journal:  J Mol Cell Cardiol       Date:  2013-06-10       Impact factor: 5.000

Review 10.  Myocardial remodelling and recovery in dilated cardiomyopathy.

Authors:  Upasana Tayal; Sanjay K Prasad
Journal:  JRSM Cardiovasc Dis       Date:  2017-10-09
View more
  2 in total

Review 1.  Connecting different heart diseases through intercellular communication.

Authors:  Tania Martins-Marques
Journal:  Biol Open       Date:  2021-09-08       Impact factor: 2.422

Review 2.  Metalloproteinases and Their Inhibitors: Potential for the Development of New Therapeutics.

Authors:  Maryam Raeeszadeh-Sarmazdeh; Linh D Do; Brianne G Hritz
Journal:  Cells       Date:  2020-05-25       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.